4.4 Article

A randomised controlled trial to evaluate the efficacy of a 6-month dietary and physical activity intervention for patients receiving androgen deprivation therapy for prostate cancer

Related references

Note: Only part of the references are listed.
Review Public, Environmental & Occupational Health

The incidence of co-morbidities related to obesity and overweight: A systematic review and meta-analysis

Daphne P. Guh et al.

BMC PUBLIC HEALTH (2009)

Article Medicine, General & Internal

Effects of Home-Based Diet and Exercise on Functional Outcomes Among Older, Overweight Long-term Cancer Survivors RENEW: A Randomized Controlled Trial

Miriam C. Morey et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)

Article Hospitality, Leisure, Sport & Tourism

Benefits of a physical activity intervention for men with prostate cancer

S. Nicole Culos-Reed et al.

JOURNAL OF SPORT & EXERCISE PSYCHOLOGY (2007)

Article Sport Sciences

Resistance training and reduction of treatment side effects in prostate cancer patients

Daniel A. Galvao et al.

MEDICINE AND SCIENCE IN SPORTS AND EXERCISE (2006)

Article Oncology

Metabolic syndrome in men with prostate cancer undergoing long-term androgen-deprivation therapy

Milena Braga-Basaria et al.

JOURNAL OF CLINICAL ONCOLOGY (2006)

Article Oncology

Resistance exercise in men receiving androgen deprivation therapy for prostate cancer

RJ Segal et al.

JOURNAL OF CLINICAL ONCOLOGY (2003)

Article Geriatrics & Gerontology

Obesity is associated with functional decline in community-dwelling rural older persons

GL Jensen et al.

JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2002)

Article Endocrinology & Metabolism

Cardiovascular morbidity and mortality associated with the metabolic syndrome

B Isomaa et al.

DIABETES CARE (2001)

Article Oncology

Fatigue in patients with prostate cancer receiving hormone therapy

P Stone et al.

EUROPEAN JOURNAL OF CANCER (2000)

Article Medicine, Research & Experimental

Statistical considerations in the intent-to-treat principle

JM Lachin

CONTROLLED CLINICAL TRIALS (2000)